Covestor’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
Covestor's KNSA Position: Q3 2026 in Review
Covestor opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 16 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2129 among its holdings. This is a return to the name: Covestor previously reported a position in KNSA as recently as Q4 2025.
Covestor first reported a position in KNSA in Q2 2023 and has held it in 11 quarters since. The position peaked at $2K in Q3 2023. 226 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Covestor held 16 shares of Kiniksa Pharmaceuticals worth $1K as of Q3 2026.
- Kiniksa Pharmaceuticals was a new Covestor position in Q3 2026.
- Kiniksa Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2129 holding.
- Covestor first reported a position in Kiniksa Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
- Covestor's Kiniksa Pharmaceuticals position peaked at $2K in Q3 2023.
- 226 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.